天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Baricitinib Impurity 64
Baricitinib Impurity 64
  • Baricitinib Impurity 64
  • Baricitinib Impurity 64
  • Baricitinib Impurity 64
  • Baricitinib Impurity 64

Baricitinib Impurity 64 NEW

Price Get Latest Price
Package 5mg 20mg 50mg
Min. Order: 1mg
Supply Ability: 10000
Update Time: 2025-05-27

Product Details

Product Name: Baricitinib Impurity 64 Min. Order: 1mg
Purity: >95% HPLC Supply Ability: 10000
Release date: 2025/05/27
Molecular Formula:: C16H16N8O3S Molecular Weight:: 400.42
Appearance: Yellow soild Storage: 2-8°C Refrigerator

Article illustration

Product Catalog:B026064
CAS No.:
Product Name:Baricitinib Impurity 64
Purity:>95% HPLC
Synonyms: Baricitinib Nitroso Impurity 64; 2-(1-(ethylsulfonyl)-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
Molecular Formula:C16H16N8O3S
Mol. Weight:400.42
Appearance: Yellow soild
Storage:2-8°C Refrigerator
Contact:WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com
Note:We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
Background:Current research on baricitinib nitroso impurity mainly focuses on detection and quantification methods. High - performance liquid chromatography - tandem mass spectrometry (HPLC - MS/MS) and other advanced analytical techniques are being used to accurately measure the content of this impurity in baricitinib samples. At the same time, studies are being carried out to investigate the factors that affect the formation and stability of the impurity. This includes exploring the impact of different reaction conditions in the synthesis process and the effect of storage temperature, humidity, and light on impurity formation. Pharmaceutical companies and regulatory agencies are working together to establish appropriate control strategies and acceptance criteria to ensure that the level of baricitinib nitroso impurity is within a safe range.


Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-01-24
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-31
$2.00/1kg
VIP2Y
Jinan Million Pharmaceutical Co., Ltd
2023-08-11
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-31
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-08-06
INQUIRY